Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding

Link to article at PubMed

Hosp Pract (1995). 2024 Feb 26. doi: 10.1080/21548331.2024.2321824. Online ahead of print.


OBJECTIVES: Use of proton pump inhibitors (PPIs) is a mainstay in treating upper gastrointestinal bleeding (UGIB). However, the beneficial effects of PPIs are not anticipated to extend beyond the duodenum and may actually contribute to risk of lower gastrointestinal bleeding (LGIB). However, in practice, PPIs are often used for inpatients with LGIB where no benefit exists.

METHODS: A retrospective chart review was performed on inpatients during a 2 year prior at an urban academic teaching hospital. Inpatients with consults to the Gastroenterology (GI) service with confirmed or highly suspected LGIB were included. Outcomes regarding PPI use and the GI consulting service recommendations in these 225 patients were evaluated.

RESULTS: 37.8% of patients were started on a PPI during their inpatient course. Of those 46% patients started on a PPI had no indication for PPI and 85% had no recommendation by the GI consultants to start a PPI. Of the 85 patients started on PPI, the GI consultants recommended stopping it in 2 (2.3%) patients. Lastly, 20 patients (9%) were discharged on PPI without an indication for PPI.

CONCLUSION: To our knowledge, this is the first study that looked at the inappropriate utilization of PPIs in patients admitted for LGIBs utilizing GI consultant recommendations. Given the large proportion of patients started on PPI without a clinical indication and continued at discharge and the paucity of GI recommendations to discontinue inappropriate use, we found that clinical care may be improved with formal GI recommendations regarding use of PPI.

PMID:38407180 | DOI:10.1080/21548331.2024.2321824

Leave a Reply

Your email address will not be published. Required fields are marked *